The reporter learned from Yuanda Pharmaceutical that the company's innovative ophthalmic drug Manmuan® for the treatment of demodex blepharitis issued the first batch of prescriptions at 11 medical institutions in Beijing, Shanghai, Guangdong and other places. Manmuan® is the first and only drug approved for the treatment of demodex blepharitis in China.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.